122 related articles for article (PubMed ID: 16740097)
1. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.
Bracklein T; Theise S; Metzler A; Spiess BM; Richter M
Am J Vet Res; 2006 Jun; 67(6):1025-32. PubMed ID: 16740097
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
Haid C; Kaps S; Gönczi E; Hässig M; Metzler A; Spiess BM; Richter M
Vet Ophthalmol; 2007; 10(5):278-84. PubMed ID: 17760705
[TBL] [Abstract][Full Text] [Related]
3. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease.
Ballin AC; Schulz B; Helps C; Sauter-Louis C; Mueller RS; Hartmann K
Vet J; 2014 Dec; 202(3):466-70. PubMed ID: 25457261
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
[TBL] [Abstract][Full Text] [Related]
5. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.
Litzlbauer P; Weber K; Mueller RS
Cytokine; 2014 Mar; 66(1):54-9. PubMed ID: 24548425
[TBL] [Abstract][Full Text] [Related]
6. The biological effects of five feline IFN-alpha subtypes.
Baldwin SL; Powell TD; Sellins KS; Radecki SV; Cohen JJ; Milhausen MJ
Vet Immunol Immunopathol; 2004 Jun; 99(3-4):153-67. PubMed ID: 15135982
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro.
Priosoeryanto BP; Tateyama S; Yamaguchi R; Uchida K
Can J Vet Res; 1995 Jan; 59(1):67-9. PubMed ID: 7704845
[TBL] [Abstract][Full Text] [Related]
8. Effects of topical ocular administration of high doses of human recombinant interferon alpha-2b and feline recombinant interferon omega on naturally occurring viral keratoconjunctivitis in cats.
Slack JM; Stiles J; Leutenegger CM; Moore GE; Pogranichniy RM
Am J Vet Res; 2013 Feb; 74(2):281-9. PubMed ID: 23363355
[TBL] [Abstract][Full Text] [Related]
9. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
[TBL] [Abstract][Full Text] [Related]
11. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
Tanabe T; Yamamoto JK
J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
[TBL] [Abstract][Full Text] [Related]
12. Serum glucose and insulin responses to an insulin-containing ophthalmic solution administered topically in clinically normal cats.
Hopper PE; Murphy CJ; Feldman EC; Nelson RW; Bottoms GD; Franti CE
Am J Vet Res; 1991 Jun; 52(6):903-7. PubMed ID: 1883093
[TBL] [Abstract][Full Text] [Related]
13. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1.
Siebeck N; Hurley DJ; Garcia M; Greene CE; Köstlin RG; Moore PA; Dietrich UM
Am J Vet Res; 2006 Aug; 67(8):1406-11. PubMed ID: 16881854
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial results on the use of a recombinant feline interferon-omega to protect Japanese pearl oysters Pinctada fucata martensii from akoya-virus infection.
Miyazaki T; Nozawa N; Kobayashi T
Dis Aquat Organ; 2000 Oct; 43(1):15-26. PubMed ID: 11129377
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.
Hampel V; Schwarz B; Kempf C; Köstlin R; Schillinger U; Küchenhoff H; Fenske N; Brill T; Hirschberger J
J Vet Intern Med; 2007; 21(6):1340-6. PubMed ID: 18196745
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
Matsumoto H; Teshima T; Iizuka Y; Sakusabe A; Takahashi D; Amimoto A; Koyama H
Res Vet Sci; 2018 Dec; 121():53-58. PubMed ID: 30359811
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration.
Paltrinieri S; Crippa A; Comerio T; Angioletti A; Roccabianca P
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):68-74. PubMed ID: 17521745
[TBL] [Abstract][Full Text] [Related]
18. Assessment of oxidative stress in leukocytes and granulocyte function following oral administration of a silibinin-phosphatidylcholine complex in cats.
Webb CB; McCord KW; Twedt DC
Am J Vet Res; 2009 Jan; 70(1):57-62. PubMed ID: 19119949
[TBL] [Abstract][Full Text] [Related]
19. Effects of salmonid fish viruses on Mx gene expression and resistance to single or dual viral infections.
Saint-Jean SR; Pérez-Prieto SI
Fish Shellfish Immunol; 2007 Aug; 23(2):390-400. PubMed ID: 17442587
[TBL] [Abstract][Full Text] [Related]
20. Ingested interferon alpha induces Mx mRNA.
Brod SA; Nelson L; Jin R; Wolinsky JS
Cytokine; 1999 Jul; 11(7):492-9. PubMed ID: 10419650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]